Plasmodium falciparum parasitaemia described by a new mathematical model

Parasitology

Volumn 122, Issue 4, 2001, Pages 379-391

  Molineaux, L ^a   Diebner, H H ^b,c   Eichner, M ^b   Collins, W E ^d   Jeffery, G M ^e   Dietz, K ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Center for Art and Media   (Germany)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e U S PUBLIC HEALTH SERVICE   (United States)

Author keywords

Malaria therapy; Mathematical model; PfEMP1; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CYTOKINE; TUMOR NECROSIS FACTOR;

ARTICLE; HUMAN; MALARIA; MALARIA CONTROL; MATHEMATICAL MODEL; NONHUMAN; PARASITEMIA; PLASMODIUM; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STOCHASTIC MODEL; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; HUMANS; MALARIA, FALCIPARUM; MODELS, BIOLOGICAL; PARASITEMIA; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0035067147     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0031182001007533     Document Type: Article

References (24)

1. Modelling Trypanosoma congolense parasitaemia patterns during the chronic phase of infection in N'Dama cattle
2. Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria
3. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria
4. Antigenic variation in malaria
5. Malaria parasites undergo antigenic variation at high rates in vivo
6. Antibody induced variation in malaria parasites
7. Immunity to malaria: Antigenic variation in chronic infections of Plasmodium knowlesi
8. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria
9. A retrospective examination of sporozoite and trophozoite-induced infections with Plasmodium falciparum: Development of parasitologic and clinical immunity during primary infection
10. Enumeration of parasites in the blood of malarial patients
11. The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host
12. Tumor necrosis factor and disease severity in children with falciparum malaria
13. Mathematical modelling of the within-host dynamics of Plasmodium falciparum
14. The duration in the human host of infections with a Panama strain of Plasmodium falciparum
15. Early activity in sporozoite-induced Plasmodium falciparum infections
16. Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production
17. Malarial toxins and the regulation of parasite density
18. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria
19. Anti-TNF therapy inhibits fever in cerebral malaria
20. Plasmodium falciparum malaria: Some epidemiological implications of parasite and host diversity
21. Review of intra-host models of malaria
22. Antigenic variation during malaria infection - The contribution from the murine parasite Plasmodium chabaudi
23. Rapid switching to multiple antigenic and adhesive phenotypes in malaria
24. The flip-side of cytoadherence: Immune selection, antigenic variation and the var genes of Plasmodium falciparum